Ellomay Capital (FRA:NUR) Margin of Safety % (DCF Earnings Based): N/A (As of Jun. 27, 2026)


FRA:NUR Ellomay Capital Ltd FRA:NUR
56 GF Score
Price €15.10
GF Value €10.55
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Ellomay Capital Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Ellomay Capital's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.


FRA:NUR vs SAFX, NXXT, STEM: Margin of Safety % (DCF Earnings Based) Comparison

For the Utilities - Renewable subindustry, Ellomay Capital's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ellomay Capital Margin of Safety % (DCF Earnings Based) vs Utilities - Independent Power Producers Industry

For the Utilities - Independent Power Producers industry and Utilities sector, Ellomay Capital's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where Ellomay Capital's Margin of Safety % (DCF Earnings Based) falls into.


FRA:NUR
56GF Score
Ellomay Capital Ltd FRA:NUR
Margin of Safety % (DCF Earnings Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Ellomay Capital (FRA:NUR) Overvalued in 2026?

Based on GuruFocus' analysis, Ellomay Capital stock appears to be overvalued. The current stock price of €15.10 is trading 43.1% above its estimated GF Value™ of €10.55. GuruFocus considers Ellomay Capital to be Significantly Overvalued.

Key valuation signals for FRA:NUR:

  • Margin of Safety % (DCF Earnings Based): N/A
  • GF Value™: €10.55 vs. price of €15.10 (43.1% above fair value)
  • GF Score™: 56/100 with 7 warning signs

No single metric tells the full story. See the FRA:NUR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Ellomay Capital Business Description

Other Exchanges ELLO:USAELLO:Israel
Address 18 Rothschild Boulevard, 1st Floor, Tel Aviv, ISR, 6688121
Ellomay Capital Ltd is a renewable energy company. It develops and operates renewable energy projects in Europe, the USA, and Israel, employing diverse technologies such as solar power, natural gas, pumped hydro, and waste-to-energy solutions. Geographically, the company operates in segments: Italy; Spain; USA; Netherland and Israel. It derives maximum revenue from Spain.
56GF Score

Get the complete analysis for FRA:NUR

Margin of Safety % (DCF Earnings Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€15.10
Price
€10.55
GF Value